Estudo randomizado | Introdução de adalimumabe vs. escalonamento de dose de metotrexato em pacientes com artrite psoriática com controle inadequado.

Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study – The Lancet Rheumatology (link para o resumo – $ para o texto completo)

Comentário:

Comentário no Twitter

NEW RESEARCH—A randomised, open-label, phase 4 trial supports the addition of #adalimumab over escalating in patients with #PsoriaticArthritis not reaching minimal disease activity after an initial methotrexate course https://t.co/LUpzAw71lD #LancetRheumatology pic.twitter.com/ouqTyITlxC

— The Lancet Rheumatology (@TheLancetRheum) February 28, 2022